All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F20%3A73601252" target="_blank" >RIV/61989592:15110/20:73601252 - isvavai.cz</a>

  • Alternative codes found

    RIV/65269705:_____/20:00073045 RIV/00216224:14740/20:00118646 RIV/00209805:_____/20:00078444

  • Result on the web

    <a href="https://www.mdpi.com/2077-0383/9/8/2440" target="_blank" >https://www.mdpi.com/2077-0383/9/8/2440</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.3390/jcm9082440" target="_blank" >10.3390/jcm9082440</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection

  • Original language description

    Pancreatic ductal adenocarcinoma (PDAC) constitutes 90% of all pancreatic cancers and is associated with the worst survival, with only 5–7% of patients living longer than five years from diagnosis [1,2]. In comparison to other types of pancreatic cancer [3], PDAC, due to its aggressive biological behavior, has a high incidence/mortality ratio reaching 94%, which makes this disease the 4th most common cause of cancer-associated mortality in developed countries [2]. Among the available treatment strategies, including radical pancreatectomy, chemotherapy, radiotherapy, or integrated multimodal treatment, radical surgical resection of the tumor in its early stages (IA–IIB) remains the only option that may increase the five-year survival rate to 16–21% [4–6].

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>ost</sub> - Miscellaneous article in a specialist periodical

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/NV16-31314A" target="_blank" >NV16-31314A: Usage of circulating microRNAs for the diagnosis of pancreatic cancer and identification of patients who will not benefit from the surgical resection</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Clinical Medicine

  • ISSN

    2077-0383

  • e-ISSN

  • Volume of the periodical

    9

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    CH - SWITZERLAND

  • Number of pages

    12

  • Pages from-to

    "nestránkováno"

  • UT code for WoS article

    000568145300001

  • EID of the result in the Scopus database